Friday, May 23, 2014 5:34:59 PM
I still really like Theralase Technologies and own quite a few shares. I am absolutely not saying to sell Titan and go out and get Theralase - it is much, much further away from commercialization, although for what it is and the current price level, I do like them.
They have an interesting story and have achieved some impressive results in the lab. The real story there is that they potentially have a cure for cancer (they're initially targeting bladder cancer). It's patented and the lab results have been impressive. The cold laser aspect of the company is merely a channel of revenue to fund the research that they are currently doing. Most small caps like Theralase need to raise capital to get funded, and while they do, at least the cold laser division partially supplements their research. It is also endorsed by the world-renowned Dr. James Andrews, who, if you ever watch sports, you surely have heard about.
I haven't been posting much on Theralase lately because I have been so focused on Titan.
I just wanted to take a few minutes and reassure some folks on here who have invested in Theralase. I've gone down to their head office and sat down with Roger and feel confident that we are going to see results from his team at some point in the future. I expect to see some real movement Q1 2015.
Bantec's Howco Short Term Department of Defense Contract Wins Will Exceed $1,100,000 for the current Quarter • BANT • Jun 25, 2024 10:00 AM
ECGI Holdings Targets $9.7 Billion Equestrian Apparel Market with Allon Brand Launch • ECGI • Jun 25, 2024 8:36 AM
Avant Technologies Addresses Progress on AI Supercomputer-Driven Data Centers • AVAI • Jun 25, 2024 8:00 AM
Green Leaf Innovations, Inc. Expands International Presence with New Partnership in Dubai • GRLF • Jun 24, 2024 8:30 AM
Bemax Inc. Positions to Capitalize on Industry Growth with New Improved Quality of Mother's Touch® Disposable Diapers • BMXC • Jun 24, 2024 8:00 AM
Last Shot Hydration Drink Announced as Official Sponsor of Red River Athletic Conference • EQLB • Jun 20, 2024 2:38 PM